Approach to the Diagnosis of Interstitial Lung Disease

Clinics in Chest Medicine

Volumn 33, Issue 1, 2012, Pages 1-10

  Behr, Jürgen ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Diagnosis; Idiopathic interstitial pneumonia; Interstitial lung disease

Indexed keywords

ALGORITHM; BLOOD GAS ANALYSIS; BRONCHOSCOPY; CLINICAL EVALUATION; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; DOCTOR PATIENT RELATION; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; INTERSTITIAL LUNG DISEASE; LABORATORY TEST; LUNG BIOPSY; LUNG FUNCTION TEST; MEDICAL HISTORY; MEDICAL SPECIALIST; PATHOLOGIST; PH MEASUREMENT; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PULMONOLOGY; RADIOLOGIST; REVIEW; SURGICAL LUNG BIOPSY; THORAX RADIOGRAPHY;

ALGORITHMS; BIOPSY, NEEDLE; BRONCHOSCOPY; DIAGNOSIS, DIFFERENTIAL; HUMANS; LUNG DISEASES, INTERSTITIAL; MEDICAL HISTORY TAKING; PHYSICAL EXAMINATION; PULMONARY FIBROSIS; RADIOGRAPHY, THORACIC; RESPIRATORY FUNCTION TESTS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84857392437     PISSN: 02725231     EISSN: 15578216     Source Type: Journal    
DOI: 10.1016/j.ccm.2011.12.002     Document Type: Review

References (27)

1. American Thoracic Society/European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2002, 165:277-304.
2. Raghu G., Collard H.R., Egan J.J., et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011, 183:788-824.
3. Bradley B., Branley H.M., Egan J.J., et al. British Thoracic Society Interstitial Lung Disease Guideline Group, British Thoracic Society Standard of Care Committee; Thoracic Society of Australia; New Zealand Thoracic Society; Irish Thoracic Society. Interstitial lung disease guideline. Thorax 2008, 63(Suppl 5):v1-v58.
4. Raghu G., Mageto Y.N., Lockhart D., et al. The accuracy of the clinical diagnosis of new-onset idiopathic pulmonary fibrosis and other interstitial lung disease: a prospective study. Chest 1999, 116:1168-1174.
5. King T.E., Tooze J.A., Schwarz M.I., et al. Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model. Am J Respir Crit Care Med 2001, 164:1171-1181.
6. Gribbin J., Hubbard R.B., Le Jeune I., et al. Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK. Thorax 2006, 61:980-985.
7. Yang S., Raghu G. Clinical evaluation. Diffuse parenchymal lung disease 2007, 22-28. Karger, Basel (Switzerland). U. Costabel, R.M. duBois, M.M. Egan (Eds.).
8. Raghu G., Freudenberger T.D., Yang S., et al. High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosis. Eur Respir J 2006, 27:136-142.
9. Diffuse Lung Disease Questionnaire for Patients. Available at: http://www.chestnet.org/accp/patient-guides/interstitial-diffuse-lung-disease-questionnaire-accp-members.
10. Cooper J.A., White D.A., Matthay R.A. Drug-induced pulmonary disease. Part 1: cytotoxic drugs. Am Rev Respir Dis 1986, 133:321-340.
11. Cooper J.A., White D.A., Matthay R.A. Drug-induced pulmonary disease. Part 2: noncytotoxic drugs. Am Rev Respir Dis 1986, 133:488-505.
12. Steele M.P., Speer M.C., Loyd J.E., et al. Clinical and pathologic features of familial interstitial pneumonia. Am J Respir Crit Care Med 2005, 172:1146-1152.
13. Costabel U., Hunninghake G.W. ATS/ERS/WASOG statement on sarcoidosis. Sarcoidosis Statement Committee. American Thoracic Society. European Respiratory Society. World Association for Sarcoidosis and Other Granulomatous Disorders. Eur Respir J 1999, 14:735-737.
14. Prasse A., Probst C., Bargagli E., et al. Serum CC-chemokine ligand 18 concentration predicts outcome in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2009, 179:717-723.
15. Behr J., Furst D.E. Pulmonary function tests. Rheumatology 2008, 47(Suppl 5):v65-v67.
16. Hoeper M.M., Andreas S., Bastian A., et al. Dtsch Med Wochenschr 2010, 135(Suppl 3):S115-S124. [in German].
17. Zappala C.J., Latsi P.I., Nicholson A.G., et al. Marginal decline in forced vital capacity is associated with a poor outcome in idiopathic pulmonary fibrosis. Eur Respir J 2010, 35:830-835.
18. Wells A.U., Desai S.R., Rubens M.B., et al. Idiopathic pulmonary fibrosis: a composite physiologic index derived from disease extent observed by computed tomography. Am J Respir Crit Care Med 2003, 167:962-969.
19. Latsi P.I., du Bois R.M., Nicholson A.G., et al. Fibrotic idiopathic interstitial pneumonia: the prognostic value of longitudinal functional trends. Am J Respir Crit Care Med 2003, 168:531-537.
20. Behr J., Demedts M., Buhl R., IFIGENIA study group, et al. Lung function in idiopathic pulmonary fibrosis-extended analyses of the IFIGENIA trial. Respir Res 2009, 10:101.
21. Ohshimo S., Bonella F., Cui A., et al. Significance of bronchoalveolar lavage for the diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2009, 179:1043-1047.
22. Chechani V., Landreneau R.J., Shaikh S.S. Open lung biopsy for diffuse infiltrative lung disease. Ann Thorac Surg 1992, 54:296-300.
23. Kreider M., Hansen-Flaschen J., Ahmad N., et al. Complications of video-assisted thoracoscopic lung biopsy in patients with interstitial lung disease. Ann Thorac Surg 2007, 83(3):1140-1144.
24. Flaherty K.R., King T.E., Raghu G., et al. Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis?. Am J Respir Crit Care Med 2004, 170:904-910.
25. Galiè N., Hoeper M.M., Humbert M., et al. Guidelines for the diagnosis and treatment of pulmonary hypertension. The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Respir J 2009, 34:1219-1263.
26. Leuchte H.H., Neurohr C., Baumgartner R., et al. Brain natriuretic peptide and exercise capacity in lung fibrosis and pulmonary hypertension. Am J Respir Crit Care Med 2004, 170:360-365.
27. Leuchte H.H., Baumgartner R.A., Nounou M.E., et al. Brain natriuretic peptide is a prognostic parameter in chronic lung disease. Am J Respir Crit Care Med 2006, 173:744-750.